Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Omae

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
International Journal of Clinical Oncology|August 24, 2016
Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapyHiroki Ishihara, Takafumi Yagisawa, Tsunenori Kondo, et al.
International Urology and Nephrology|May 20, 2016
Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney diseaseToshio Takagi, Tsunenori Kondo, Kenji Omae, et al.
Urologic Oncology|June 19, 2017
Effect of ABO blood type on the outcomes of patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitorsKenji Omae, Shingo Fukuma, Tatsuyoshi Ikenoue, et al.
Urology|July 19, 2015
Assessment of Surgical Outcomes of the Non-renorrhaphy Technique in Open Partial Nephrectomy for ≥T1b Renal TumorsToshio Takagi, Tsunenori Kondo, Kenji Omae, et al.
International Journal of Clinical Oncology|July 12, 2015
Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysisKenji Omae, Tsunenori Kondo, Takafumi Kennoki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 16, 2017
Robot-assisted laparoscopic versus open partial nephrectomy in patients with chronic kidney disease: A propensity score-matched comparative analysis of surgical outcomesToshio Takagi, Tsunenori Kondo, Hidekazu Tachibana, et al.
International Journal of Clinical Oncology|July 17, 2016
Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution studyHiroki Ishihara, Tsunenori Kondo, Kenji Omae, et al.
Japanese Journal of Clinical Oncology|August 21, 2014
Clinical symptoms predict poor overall survival in chronic-dialysis patients with renal cell carcinoma associated with end-stage renal diseaseEri Ikezawa, Tsunenori Kondo, Yasunobu Hashimoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 30, 2013
Better recovery of kidney function in patients with de novo chronic kidney disease after partial nephrectomy compared with those with pre-existing chronic kidney diseaseToshio Takagi, Tsunenori Kondo, Junpei Iizuka, et al.
Japanese Journal of Clinical Oncology|December 30, 2016
Evaluation of tumor burden after sequential molecular-targeted therapy in patients with metastatic renal cell carcinomaHiroki Ishihara, Tsunenori Kondo, Kazuhiko Yoshida, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
International Journal of Clinical Oncology|August 24, 2016
Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapyHiroki Ishihara, Takafumi Yagisawa, Tsunenori Kondo, et al.
International Urology and Nephrology|May 20, 2016
Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney diseaseToshio Takagi, Tsunenori Kondo, Kenji Omae, et al.
Urologic Oncology|June 19, 2017
Effect of ABO blood type on the outcomes of patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitorsKenji Omae, Shingo Fukuma, Tatsuyoshi Ikenoue, et al.
Urology|July 19, 2015
Assessment of Surgical Outcomes of the Non-renorrhaphy Technique in Open Partial Nephrectomy for ≥T1b Renal TumorsToshio Takagi, Tsunenori Kondo, Kenji Omae, et al.
International Journal of Clinical Oncology|July 12, 2015
Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysisKenji Omae, Tsunenori Kondo, Takafumi Kennoki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 16, 2017
Robot-assisted laparoscopic versus open partial nephrectomy in patients with chronic kidney disease: A propensity score-matched comparative analysis of surgical outcomesToshio Takagi, Tsunenori Kondo, Hidekazu Tachibana, et al.
International Journal of Clinical Oncology|July 17, 2016
Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution studyHiroki Ishihara, Tsunenori Kondo, Kenji Omae, et al.
Japanese Journal of Clinical Oncology|August 21, 2014
Clinical symptoms predict poor overall survival in chronic-dialysis patients with renal cell carcinoma associated with end-stage renal diseaseEri Ikezawa, Tsunenori Kondo, Yasunobu Hashimoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 30, 2013
Better recovery of kidney function in patients with de novo chronic kidney disease after partial nephrectomy compared with those with pre-existing chronic kidney diseaseToshio Takagi, Tsunenori Kondo, Junpei Iizuka, et al.
Japanese Journal of Clinical Oncology|December 30, 2016
Evaluation of tumor burden after sequential molecular-targeted therapy in patients with metastatic renal cell carcinomaHiroki Ishihara, Tsunenori Kondo, Kazuhiko Yoshida, et al.
Pageof 11